Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits

E Perger, S Bertoli, C Lombardi - Expert Review of Respiratory …, 2023 - Taylor & Francis
Introduction The pathophysiology of obstructive sleep apnea (OSA) is multi-factorial and
complex. Varying OSA's pathophysiological traits have been identified, including pharyngeal …

The individual and societal prices of non-adherence to continuous positive airway pressure, contributors, and strategies for improvement

M Mendelson, J Duval, F Bettega… - Expert Review of …, 2023 - Taylor & Francis
Introduction Continuous positive airway pressure (CPAP) is the first-line therapy for
obstructive sleep apnea (OSA). CPAP is highly effective for improving symptoms and quality …

Moving toward equitable care for sleep apnea in the United States: positive airway pressure adherence thresholds: an official American Thoracic Society policy …

AM May, SR Patel, M Yamauchi, TK Verma… - American journal of …, 2023 - atsjournals.org
Background: Positive airway pressure (PAP) is a highly effective treatment for obstructive
sleep apnea (OSA), but adherence limits its efficacy. In addition, coverage of PAP by CMS …

Adherence to CPAP Treatment: Can Mindfulness Play a Role?

A Pataka, SC Kotoulas, PR Gavrilis, A Karkala… - Life, 2023 - mdpi.com
Obstructive sleep apnea (OSA) is considered a chronic disease that requires long-term
multidisciplinary management for effective treatment. Continuous Positive Airway Pressure …

Identifying longitudinal patterns of CPAP treatment in OSA using growth mixture modeling: Disease characteristics and psychological determinants

H Yi, X Dong, S Shang, C Zhang, L Xu, F Han - Frontiers in Neurology, 2022 - frontiersin.org
In this study, we aim to identify the distinct subtypes of continuous positive airway pressure
(CPAP) user profiles based on the telemedicine management platform and to determine …

Assessment and management of continuous positive airway pressure therapy in patient with obstructive sleep apnea

Y Fujita, M Yamauchi, S Muro - Respiratory Investigation, 2024 - Elsevier
Obstructive sleep apnea (OSA) causes excessive daytime sleepiness, impaired daytime
functioning, and an increased risk of cardiovascular diseases. Continuous positive airway …

Pharmacotherapy for obstructive sleep apnoea and coupled life: A descriptive phenomenological study of a complex interaction

D Rosa, E Perger, G Villa, L Bonetti, V Storti, E Cartabia… - Healthcare, 2022 - mdpi.com
Background: Obstructive Sleep Apnoea (OSA) is a common chronic sleep-related breathing
disorder. Drug therapy is a recent approach to treating OSA, and no data is available …

CPAP for secondary cardiovascular prevention in obstructive sleep apnoea patients: not only one moon, but many stars

S Baillieul, NM Shah, R Dharmasena, S Schiza… - Breathe, 2022 - Eur Respiratory Soc
While continuous positive airway pressure (CPAP) therapy has a strong evidence base for
the treatment of obstructive sleep apnoea (OSA), its impact on cardiovascular comorbidity …

Желудочковые аритмии у пациентов с хронической сердечной недостаточностью и центральным апноэ сна с дыханием Чейн-Стокса

ЕМ Середенина, ЕС Красильникова… - Южно-Российский …, 2024 - therapeutic-j.ru
Аннотация Обзор посвящён вопросам влияния центрального апноэ сна и дыхания Чейн-
Стокса на прогноз пациентов с хронической сердечной недостаточностью …

Patients' experiences of barriers and facilitators with continuous positive airway pressure therapy in obstructive sleep apnoea–a qualitative interview study

K Jeppesen, AR Good, ID Dyrhaug, MB Johansen… - 2024 - researchsquare.com
Background: The prevalence of obstructive sleep apnoea ranges from 6% to 17% in the
general adult population. Untreated obstructive sleep apnoea is associated with …